
Rong Le
Examiner (ID: 6693, Phone: (571)270-7637 , Office: P/2423 )
| Most Active Art Unit | 2421 |
| Art Unit(s) | 2423, 2421 |
| Total Applications | 494 |
| Issued Applications | 304 |
| Pending Applications | 67 |
| Abandoned Applications | 142 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13636713
[patent_doc_number] => 09845313
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-19
[patent_title] => Cycloalkane derivatives
[patent_app_type] => utility
[patent_app_number] => 15/269485
[patent_app_country] => US
[patent_app_date] => 2016-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 77505
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15269485
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/269485 | Cycloalkane derivatives | Sep 18, 2016 | Issued |
Array
(
[id] => 12362490
[patent_doc_number] => 09955688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Biocidal aldehyde composition
[patent_app_type] => utility
[patent_app_number] => 15/212404
[patent_app_country] => US
[patent_app_date] => 2016-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5137
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15212404
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/212404 | Biocidal aldehyde composition | Jul 17, 2016 | Issued |
Array
(
[id] => 14849661
[patent_doc_number] => 10413535
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-17
[patent_title] => Pharmaceutical compositions comprising an integrin ALPHA4 antagonist for use in treating ocular inflammatory conditions
[patent_app_type] => utility
[patent_app_number] => 15/742867
[patent_app_country] => US
[patent_app_date] => 2016-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 17057
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15742867
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/742867 | Pharmaceutical compositions comprising an integrin ALPHA4 antagonist for use in treating ocular inflammatory conditions | Jul 6, 2016 | Issued |
Array
(
[id] => 11099523
[patent_doc_number] => 20160296493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING PEDIATRIC EPILEPSY AND EPILEPSY-RELATED SYNDROMES'
[patent_app_type] => utility
[patent_app_number] => 15/190123
[patent_app_country] => US
[patent_app_date] => 2016-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 37100
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15190123
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/190123 | Phenyl carbamate compounds for use in preventing or treating pediatric epilepsy and epilepsy-related syndromes | Jun 21, 2016 | Issued |
Array
(
[id] => 12832570
[patent_doc_number] => 20180169362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => TRACHEOSTOMY TUBE ASSEMBLIES AND INNER CANNULAE
[patent_app_type] => utility
[patent_app_number] => 15/736449
[patent_app_country] => US
[patent_app_date] => 2016-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2329
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736449
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/736449 | TRACHEOSTOMY TUBE ASSEMBLIES AND INNER CANNULAE | Jun 14, 2016 | Abandoned |
Array
(
[id] => 11082156
[patent_doc_number] => 20160279121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => '5-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE, SALTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/180727
[patent_app_country] => US
[patent_app_date] => 2016-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4040
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15180727
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/180727 | 5-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE, SALTS AND USES THEREOF | Jun 12, 2016 | Abandoned |
Array
(
[id] => 11309466
[patent_doc_number] => 20160345576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'PERACETIC ACID COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/168630
[patent_app_country] => US
[patent_app_date] => 2016-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5913
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15168630
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/168630 | PERACETIC ACID COMPOSITION | May 30, 2016 | Abandoned |
Array
(
[id] => 11046099
[patent_doc_number] => 20160243058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/142519
[patent_app_country] => US
[patent_app_date] => 2016-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14943
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15142519
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/142519 | COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS | Apr 28, 2016 | Abandoned |
Array
(
[id] => 11046136
[patent_doc_number] => 20160243094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/142133
[patent_app_country] => US
[patent_app_date] => 2016-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14947
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15142133
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/142133 | COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS | Apr 28, 2016 | Abandoned |
Array
(
[id] => 11053199
[patent_doc_number] => 20160250161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/142492
[patent_app_country] => US
[patent_app_date] => 2016-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14945
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15142492
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/142492 | COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS | Apr 28, 2016 | Abandoned |
Array
(
[id] => 11046138
[patent_doc_number] => 20160243095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/142253
[patent_app_country] => US
[patent_app_date] => 2016-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14946
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15142253
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/142253 | COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS | Apr 28, 2016 | Abandoned |
Array
(
[id] => 11269173
[patent_doc_number] => 20160331719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'NATURAL PRODUCT ANTIBIOTICS AND ANALOGS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/136746
[patent_app_country] => US
[patent_app_date] => 2016-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 39109
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15136746
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/136746 | NATURAL PRODUCT ANTIBIOTICS AND ANALOGS THEREOF | Apr 21, 2016 | Abandoned |
Array
(
[id] => 11046079
[patent_doc_number] => 20160243035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/090396
[patent_app_country] => US
[patent_app_date] => 2016-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14923
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15090396
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/090396 | COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS | Apr 3, 2016 | Abandoned |
Array
(
[id] => 11023591
[patent_doc_number] => 20160220545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/090416
[patent_app_country] => US
[patent_app_date] => 2016-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14926
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15090416
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/090416 | COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS | Apr 3, 2016 | Abandoned |
Array
(
[id] => 11053188
[patent_doc_number] => 20160250149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/090400
[patent_app_country] => US
[patent_app_date] => 2016-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14926
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15090400
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/090400 | COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS | Apr 3, 2016 | Abandoned |
Array
(
[id] => 11046135
[patent_doc_number] => 20160243093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/090429
[patent_app_country] => US
[patent_app_date] => 2016-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14923
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15090429
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/090429 | COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS | Apr 3, 2016 | Abandoned |
Array
(
[id] => 11469558
[patent_doc_number] => 20170056340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-02
[patent_title] => 'Composition for Administering an NMDA Receptor Antagonist to a Subject'
[patent_app_type] => utility
[patent_app_number] => 15/089062
[patent_app_country] => US
[patent_app_date] => 2016-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15798
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15089062
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/089062 | Composition for Administering an NMDA Receptor Antagonist to a Subject | Mar 31, 2016 | Abandoned |
Array
(
[id] => 12637815
[patent_doc_number] => 20180104435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => OXYGEN SUPPLY DEVICE, OXYGEN SUPPLY SYSTEM AND METHOD OF OXYGEN SUPPLY
[patent_app_type] => utility
[patent_app_number] => 15/562604
[patent_app_country] => US
[patent_app_date] => 2016-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7009
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15562604
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/562604 | OXYGEN SUPPLY DEVICE, OXYGEN SUPPLY SYSTEM AND METHOD OF OXYGEN SUPPLY | Mar 31, 2016 | Abandoned |
Array
(
[id] => 11106152
[patent_doc_number] => 20160303123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'CHROMENE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/079740
[patent_app_country] => US
[patent_app_date] => 2016-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16357
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15079740
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/079740 | Chromene derivatives as phoshoinositide 3-kinases inhibitors | Mar 23, 2016 | Issued |
Array
(
[id] => 11002413
[patent_doc_number] => 20160199362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'METHOD FOR THE TREATMENT, ALLEVIATION OF SYMPTOMS OF, RELIEVING, IMPROVING AND PREVENTING A COGNITIVE DISEASE, DISORDER OR CONDITION'
[patent_app_type] => utility
[patent_app_number] => 15/074580
[patent_app_country] => US
[patent_app_date] => 2016-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16419
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15074580
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/074580 | METHOD FOR THE TREATMENT, ALLEVIATION OF SYMPTOMS OF, RELIEVING, IMPROVING AND PREVENTING A COGNITIVE DISEASE, DISORDER OR CONDITION | Mar 17, 2016 | Abandoned |